| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2024 | NPCE Neuropace Inc | Kck Ltd. | 10% Owner | Sell | 39,684 | $6.92 | $274,713.90 | - | +61.5% | +50.5% | |
| Oct 1, 2024 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 2,958 | $148.24 | $438,490.90 | -1.5% | -59.1% | -20.7% | |
| Oct 1, 2024 | PEN Penumbra Inc | Kassing Don W.49 | Director | Sell | 170 | $193.93 | $32,968.10 | -16.9% | +24.3% | +30.3% | |
| Oct 1, 2024 | AORT Artivion, Inc. | Horton Amy48 | VP, Chief Accounting Officer | Sell | 12,430 | $26.18 | $325,414.91 | -8.2% | +8.8% | +56.5% | |
| Oct 1, 2024 | PEN Penumbra Inc | Roberts Johanna54 | EVP, Gen. Counsel &Secretary | Sell | 600 | $190.76 | $114,455.67 | -0.1% | +24.3% | +30.3% | |
| Oct 1, 2024 | SGHT Sight Sciences, Inc. | Park Sam Boong67 | Chief Operating Officer | Sell | 3,403 | $6.08 | $20,690.24 | -1.3% | -41.7% | -44.7% | |
| Oct 1, 2024 | ICUI Icu Medical Inc/de | Jain Vivek83 | Chairman And CEO | Sell | 12,000 | $178.46 | $2,141,579.92 | -2.7% | -13.9% | -32.5% | |
| Oct 1, 2024 | RXST Rxsight, Inc. | Thunen Shelley B74 | See Remarks | Sell | 15,000 | $48.45 | $726,729.73 | -12.9% | -28.3% | -80.9% | |
| Oct 1, 2024 | SGHT Sight Sciences, Inc. | Hayden Jeremy B.63 | Chief Legal Officer | Sell | 4,878 | $6.08 | $29,658.24 | -3.0% | -41.7% | -44.7% | |
| Oct 1, 2024 | SGHT Sight Sciences, Inc. | Bauerlein Alison73 | Chief Financial Officer | Sell | 10,130 | $6.08 | $61,590.40 | -2.5% | -41.7% | -44.7% | |
| Oct 1, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 5,744 | $0.75 | $4,319.49 | - | -8.9% | +9.6% | |
| Oct 1, 2024 | BFLY Butterfly Network, Inc. | Stoica Andrei G53 | Chief Technology Officer | Sell | 1,696 | $1.79 | $3,034.14 | -0.1% | +94.6% | +14.5% | |
| Oct 1, 2024 | BSX Boston Scientific Corp | Carruthers Wendy | EVP, Human Resources | Sell | 6,983 | $83.86 | $585,594.38 | -16.7% | +6.6% | +13.9% | |
| Sep 30, 2024 | PACB Pacific Biosciences Of California, Inc. | Kim Susan G.77 | See Remarks | Sell | 19,782 | $1.72 | $34,064.60 | -2.8% | +5.3% | -24.7% | |
| Sep 30, 2024 | RDGL Vivos Inc | Korenko Michael K | CEO And President | Buy | 50,000 | $0.16 | $7,955.00 | +0.5% | - | - | |
| Sep 30, 2024 | RXST Rxsight, Inc. | Goldshleger Ilya81 | See Remarks | Sell | 6,205 | $49.15 | $305,000.14 | -4.6% | -31.6% | -81.8% | |
| Sep 26, 2024 | MXCT Maxcyte, Inc. | Johnston John Joseph75 | Director | Sell | 3,000 | $3.82 | $11,460.00 | -2.1% | +4.6% | -60.7% | |
| Sep 26, 2024 | XAIR Beyond Air, Inc. | Lisi Steven A.50 | CEO And Chairman Of The Board | Buy | 1,476,626 | $0.50 | $744,662.49 | +83.3% | +18.4% | -67.6% | |
| Sep 26, 2024 | XAIR Beyond Air, Inc. | Carey Robert | Director | Buy | 1,476,626 | $0.50 | $744,662.49 | New | +18.4% | -67.6% | |
| Sep 25, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 9,663 | $0.73 | $7,021.14 | - | -12.2% | +14.5% | |
| Sep 24, 2024 | MLSS Milestone Scientific Inc. | McGeehan Michael72 | Director | Sell | 209 | $1.00 | $209.00 | - | -11.2% | -51.8% | |
| Sep 24, 2024 | BFLY Butterfly Network, Inc. | Stoica Andrei G53 | Chief Technology Officer | Sell | 3,296 | $1.74 | $5,735.04 | -0.2% | +84.1% | +26.2% | |
| Sep 24, 2024 | QSI Quantum-Si Inc | Vieceli John S.49 | Chief Product Officer | Sell | 4,309 | $0.94 | $4,043.70 | -1.3% | +40.0% | +72.1% | |
| Sep 23, 2024 | LUCY Innovative Eyewear Inc | Galkin Vladimir46 | 10% Owner | Buy | 200,792 | $9.08 | $1,822,973.07 | +4.5% | -38.3% | -77.3% | |
| Sep 23, 2024 | INFU Infusystem Holdings, Inc | Eichenbaum Kenneth D. | Director | Buy | 4,000 | $5.89 | $23,560.00 | New | +36.5% | +71.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.